MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
MariMed's shares outstanding was 403M at Sep 30, 2026. For fiscal 2025 it was 390M, up 2.9% from the year before. Over ten years it grew 28.4% a year on average. The highest annual figure on record is 390M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 390M | +2.9% |
| FY2024 | Dec 31, 2024 | 379M | +4.3% |
| FY2023 | Dec 31, 2023 | 363M | -4.4% |
| FY2022 | Dec 31, 2022 | 380M | +2.1% |
| FY2021 | Dec 31, 2021 | 372M | +14.9% |
| FY2020 | Dec 31, 2020 | 324M | +55.3% |
| FY2019 | Dec 31, 2019 | 209M | +8.5% |
| FY2018 | Dec 31, 2018 | 192M | +65.4% |
| FY2017 | Dec 31, 2017 | 116M | +123.5% |
| FY2016 | Dec 31, 2016 | 52M | +62.7% |
| FY2015 | Dec 31, 2015 | 32M | +0.2% |
| FY2014 | Dec 31, 2014 | 32M | +5.2% |
| FY2013 | Dec 31, 2013 | 30M | +53.1% |
| FY2012 | Dec 31, 2012 | 20M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 403M | +2.6% |
| Q2 FY2026 | Jun 30, 2026 | 400M | +2.5% |
| Q1 FY2026 | Mar 31, 2026 | 397M | +3.9% |
| Q4 FY2025 | Dec 31, 2025 | 395M | +3.7% |
| Q3 FY2025 | Sep 30, 2025 | 393M | +3.2% |
| Q2 FY2025 | Jun 30, 2025 | 390M | +2.7% |
| Q1 FY2025 | Mar 31, 2025 | 383M | +2.0% |
| Q4 FY2024 | Dec 31, 2024 | 381M | +1.4% |
| Q3 FY2024 | Sep 30, 2024 | 381M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | 380M | +5.1% |
| Q1 FY2024 | Mar 31, 2024 | 375M | +9.5% |
| Q4 FY2023 | Dec 31, 2023 | 376M | -1.4% |
| Q3 FY2023 | Sep 30, 2023 | 373M | -2.1% |
| Q2 FY2023 | Jun 30, 2023 | 361M | -4.8% |
| Q1 FY2023 | Mar 31, 2023 | 343M | -9.5% |
| Q4 FY2022 | Dec 31, 2022 | 382M | +0.7% |
| Q3 FY2022 | Sep 30, 2022 | 381M | +11.8% |
| Q2 FY2022 | Jun 30, 2022 | 380M | -28.8% |
| Q1 FY2022 | Mar 31, 2022 | 379M | +9.5% |
| Q4 FY2021 | Dec 31, 2021 | 379M | +52.8% |
| Q1 FY2021 | Mar 31, 2021 | 341M | +47.7% |
| Q4 FY2020 | Dec 31, 2020 | 533M | +177.8% |
| Q3 FY2020 | Sep 30, 2020 | 346M | +59.2% |
| Q2 FY2020 | Jun 30, 2020 | 248M | +6.5% |
| Q1 FY2020 | Mar 31, 2020 | 231M | +8.9% |
| Q4 FY2019 | Dec 31, 2019 | 192M | -8.0% |
| Q3 FY2019 | Sep 30, 2019 | 217M | +10.7% |
| Q2 FY2019 | Jun 30, 2019 | 233M | +24.7% |
| Q1 FY2019 | Mar 31, 2019 | 212M | +18.5% |
| Q4 FY2018 | Dec 31, 2018 | 209M | +21.9% |
| Q3 FY2018 | Sep 30, 2018 | 196M | +20.0% |
| Q2 FY2018 | Jun 30, 2018 | 187M | +184.5% |
| Q1 FY2018 | Mar 31, 2018 | 179M | +178.6% |
| Q4 FY2017 | Dec 31, 2017 | 171M | +229.0% |
| Q3 FY2017 | Sep 30, 2017 | 164M | +155.5% |
| Q2 FY2017 | Jun 30, 2017 | 66M | – |
| Q1 FY2017 | Mar 31, 2017 | 64M | – |
| Q4 FY2016 | Dec 31, 2016 | 52M | – |
| Q3 FY2016 | Sep 30, 2016 | 64M | – |
See a number that looks wrong?